SG11202004946UA - Pyrrole derivatives as acc inhibitors - Google Patents
Pyrrole derivatives as acc inhibitorsInfo
- Publication number
- SG11202004946UA SG11202004946UA SG11202004946UA SG11202004946UA SG11202004946UA SG 11202004946U A SG11202004946U A SG 11202004946UA SG 11202004946U A SG11202004946U A SG 11202004946UA SG 11202004946U A SG11202004946U A SG 11202004946UA SG 11202004946U A SG11202004946U A SG 11202004946UA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrrole derivatives
- acc inhibitors
- acc
- inhibitors
- pyrrole
- Prior art date
Links
- 229940121373 acetyl-coa carboxylase inhibitor Drugs 0.000 title 1
- 150000003233 pyrroles Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17380025 | 2017-12-11 | ||
PCT/EP2018/084039 WO2019115405A1 (en) | 2017-12-11 | 2018-12-07 | Pyrrole derivatives as acc inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202004946UA true SG11202004946UA (en) | 2020-07-29 |
Family
ID=60923327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202004946UA SG11202004946UA (en) | 2017-12-11 | 2018-12-07 | Pyrrole derivatives as acc inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US20210220328A1 (en) |
EP (1) | EP3724182A1 (en) |
JP (1) | JP2021505685A (en) |
KR (1) | KR20200097697A (en) |
CN (1) | CN111886230A (en) |
AR (1) | AR113925A1 (en) |
AU (1) | AU2018382422B2 (en) |
BR (1) | BR112020005829A2 (en) |
CA (1) | CA3083990A1 (en) |
CL (1) | CL2020001534A1 (en) |
CO (1) | CO2020007044A2 (en) |
EA (1) | EA202091400A1 (en) |
IL (1) | IL275195A (en) |
MA (1) | MA51133A (en) |
MX (1) | MX2020005880A (en) |
PH (1) | PH12020550608A1 (en) |
SG (1) | SG11202004946UA (en) |
TW (1) | TW201930265A (en) |
WO (1) | WO2019115405A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2914832T3 (en) | 2017-12-11 | 2022-06-16 | Univ Muenchen Tech | PSMA Ligands for Imaging and Endorradiotherapy |
WO2020245297A1 (en) * | 2019-06-06 | 2020-12-10 | Almirall, S.A. | Pyrrole derivatives as acc inhibitors |
EP4014964A1 (en) | 2020-12-21 | 2022-06-22 | Almirall S.A. | Topical formulation |
CN113683546A (en) * | 2021-07-27 | 2021-11-23 | 厦门医学院 | Alkyl pyrrole aldehyde derivative and preparation method and application thereof |
DE102022201277A1 (en) | 2022-02-08 | 2023-08-10 | Beiersdorf Aktiengesellschaft | Novel TOFA analogues, sebum reduction preparations containing such analogues and the cosmetic and/or therapeutic use of such analogues as an effective principle for sebum reduction or prevention |
DE102022201276A1 (en) | 2022-02-08 | 2023-08-10 | Beiersdorf Aktiengesellschaft | Novel TOFA analogues, sebum reduction preparations containing such analogues and the cosmetic and/or therapeutic use of such analogues as an effective principle for sebum reduction or prevention |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4382143A (en) * | 1979-07-23 | 1983-05-03 | American Cyanamid Company | Hypolipidemic and antiatherosclerotic novel (monosubstituted-amino)heteroaryl carboxylic acids and analogs |
DE4325204C2 (en) * | 1993-07-27 | 2002-11-28 | Matthias Lehr | Acylpyrrolealcanoic acids and their derivatives as inhibitors of phospholipase A¶2¶ |
MX2016002479A (en) | 2013-09-12 | 2016-05-31 | Pfizer | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris. |
-
2018
- 2018-11-28 TW TW107142380A patent/TW201930265A/en unknown
- 2018-12-07 BR BR112020005829-7A patent/BR112020005829A2/en not_active Application Discontinuation
- 2018-12-07 CA CA3083990A patent/CA3083990A1/en not_active Abandoned
- 2018-12-07 EP EP18829230.4A patent/EP3724182A1/en not_active Withdrawn
- 2018-12-07 AU AU2018382422A patent/AU2018382422B2/en not_active Ceased
- 2018-12-07 US US16/768,940 patent/US20210220328A1/en not_active Abandoned
- 2018-12-07 WO PCT/EP2018/084039 patent/WO2019115405A1/en unknown
- 2018-12-07 SG SG11202004946UA patent/SG11202004946UA/en unknown
- 2018-12-07 KR KR1020207015520A patent/KR20200097697A/en unknown
- 2018-12-07 EA EA202091400A patent/EA202091400A1/en unknown
- 2018-12-07 JP JP2020550904A patent/JP2021505685A/en active Pending
- 2018-12-07 MA MA051133A patent/MA51133A/en unknown
- 2018-12-07 CN CN201880080059.2A patent/CN111886230A/en active Pending
- 2018-12-07 MX MX2020005880A patent/MX2020005880A/en unknown
- 2018-12-11 AR ARP180103610A patent/AR113925A1/en unknown
-
2020
- 2020-05-11 PH PH12020550608A patent/PH12020550608A1/en unknown
- 2020-06-07 IL IL275195A patent/IL275195A/en unknown
- 2020-06-09 CL CL2020001534A patent/CL2020001534A1/en unknown
- 2020-06-10 CO CONC2020/0007044A patent/CO2020007044A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR113925A1 (en) | 2020-07-01 |
TW201930265A (en) | 2019-08-01 |
AU2018382422A1 (en) | 2020-04-16 |
WO2019115405A1 (en) | 2019-06-20 |
AU2018382422B2 (en) | 2020-07-23 |
IL275195A (en) | 2020-07-30 |
JP2021505685A (en) | 2021-02-18 |
NZ762906A (en) | 2020-09-25 |
CL2020001534A1 (en) | 2020-09-04 |
KR20200097697A (en) | 2020-08-19 |
PH12020550608A1 (en) | 2021-02-15 |
CO2020007044A2 (en) | 2020-08-31 |
CN111886230A (en) | 2020-11-03 |
MA51133A (en) | 2020-10-21 |
EP3724182A1 (en) | 2020-10-21 |
MX2020005880A (en) | 2020-08-13 |
US20210220328A1 (en) | 2021-07-22 |
EA202091400A1 (en) | 2020-10-14 |
BR112020005829A2 (en) | 2020-09-24 |
CA3083990A1 (en) | 2019-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267343A (en) | Pyrazole derivatives as malt1 inhibitors | |
ZA201904568B (en) | Benzodiazepine derivatives as rsv inhibitors | |
HK1255269A1 (en) | Heteroaryl derivatives as parp inhibitors | |
IL268614A (en) | Aminotriazolopyridines as kinase inhibitors | |
IL275195A (en) | Pyrrole derivatives as acc inhibitors | |
HRP20190127T1 (en) | Pyrrolidinone derivatives as metap-2 inhibitors | |
EP3297437A4 (en) | Heterocyclic compounds as kinase inhibitors | |
EP3394068A4 (en) | Tdo2 inhibitors | |
IL274207B (en) | Aminoimidazopyridazines as kinase inhibitors | |
HK1257565A1 (en) | New trifluoromethylpropanamide derivatives as htra1 inhibitors | |
EP3684772C0 (en) | Cyclic iminopyrimidine derivatives as kinase inhibitors | |
HK1257567A1 (en) | New difluoroketamide derivatives as htra1 inhibitors | |
HK1252767A1 (en) | Pyrazol-pyridine derivatives as eaat3 inhibitors | |
IL269144A (en) | Pyrrolotriazine derivatives as kinase inhibitor | |
EP3347357A4 (en) | Heterocyclic tec-family kinase inhibitors |